A Hybrid Structural Approach to Analyze Ligand Binding by the 5-HT4 Receptor

News   Feb 15, 2013

 
A Hybrid Structural Approach to Analyze Ligand Binding by the 5-HT4 Receptor
 
 
 

RELATED ARTICLES

Discovery Could Lead to New Therapies for Diabetics

News

An enzyme previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetes. The significance of the identification of a common molecular mechanism is that many more patients could potentially benefit from drugs that target this mechanism.

READ MORE

3D Structure of DHHC Proteins Provides Blueprint for Drug Design

News

The first three-dimensional structure of DHHC proteins — enzymes involved in many cellular processes, including cancer — explains how they function and may offer a blueprint for designing therapeutic drugs.

READ MORE

Researchers Identify Druggable Genomic Targets in Malaria Parasite

News

Using whole-genome analysis and chemogenomics, scientists have discovered novel antimalarial drug targets and drug-resistance genes. The researchers analyzed >250 Plasmodium falciparum cell lines, which were resistant to 37 different anti-malarial compounds.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE